Flare Therapeutics
PrivateLast Round
Series C
Jun 30, 2026
Est. Valuation
$161.62M
Total Funding Raised
$290M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Flare Therapeutics is a biotechnology company that develops small-molecule precision medicines targeting transcription factors for the treatment of cancer and other severe diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Flare Therapeutics Comparables
Compare Flare Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kronos Bio | 79% | |
| Forkhead Biotherapeutics, Inc. | 78% | |
| HotSpot Therapeutics | 77% |
Flare Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jun 30, 2026 | ||||
| Series B | Mar 22, 2023 | ||||
| Series A | May 13, 2021 |
Flare Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agent Capital | Series C, Series B |
| Boxer Capital | Series A, Series C, Series B |
| GordonMD Global Investments | Series C, Series B |
| Eventide Funds | Series B, Series A, Series C |
| Invus Opportunities | Series B, Series A, Series C |
| Pavilion Capital | Series B |
| Pfizer Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors increased 51% MoM.
- Jun 30, 2026
$85M round led by Nextech Invest and Third Rock Ventures.
Recent news
Latest coverage and updates
- receives_financingJul 1, 2026
Flare Therapeutics Inc. received financing of $85M in Series C on Jul 1st '26.
- hiresJun 30, 2026
Flare Therapeutics Inc. hired Anna Protopapas as Chief Executive Officer on Jun 29th '26.
Flare Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Flare Therapeutics's valuation, stock price, and market status.
Is Flare Therapeutics a public or private company?
Flare Therapeutics is a private company.
What is the current stock price of Flare Therapeutics?
Flare Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Flare Therapeutics worth (valuation)?
Valuation information for Flare Therapeutics is not publicly available.
Can I buy Flare Therapeutics stock?
Flare Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Flare Therapeutics's last funding round?
Flare Therapeutics's most recent funding round was Series C on June 30, 2026.
Who are the main investors in Flare Therapeutics?
Key investors in Flare Therapeutics include GordonMD Global Investments, Pfizer Ventures, Nextech Invest, Pfizer, Third Rock Ventures.
Will Flare Therapeutics IPO soon?
No public IPO plans have been announced for Flare Therapeutics.
How can I track Flare Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Flare Therapeutics's secondary market activity and sign up for updates.